Similar articles

• Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

  Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J. Goodwin G, et al. Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2. Eur Neuropsychopharmacol. 2009. PMID: 19411165
• Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.

  Ahn YM, Lee KY, Kim CE, Kim JJ, Kang DY, Jun TY, Choi JS, Chung IW, Kim SH, Hwang SS, Kim YS. Ahn YM, et al. J Clin Psychopharmacol. 2009 Apr;29(2):117-23. doi: 10.1097/JCP.0b013e31819a6995. J Clin Psychopharmacol. 2009. PMID: 19512972 Clinical Trial.
• [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

  Bret P, Bret MC, Queuille E. Bret P, et al. Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. Encephale. 2009. PMID: 19393381 French.
• [25 years antipsychotics: back to the future?].

  Denys D, de Haan L. Denys D, et al. Tijdschr Psychiatr. 2008;50 Spec no.:105-9. Tijdschr Psychiatr. 2008. PMID: 19067308 Review. Dutch.
• Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.

  Kertzman S, Reznik I, Grinspan H, Weizman A, Kotler M. Kertzman S, et al. Isr J Psychiatry Relat Sci. 2008;45(2):114-20. Isr J Psychiatry Relat Sci. 2008. PMID: 18982837 Review.